Clinical Trial Update: Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the decolonization rate and acceptance of a povidone-iodine nasal decolonization kit for MRSA patients; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection

Drugs mentioned

• Povidone-iodine nasal decolonization kit (povidone-iodine)

Snippet

Sponsor: Nantes University Hospital | Conditions: MRSA | Phase 2 | Status: TERMINATED